ENXTPA:ORP

Stock Analysis Report

ORPEA Société Anonyme

Executive Summary

ORPEA Société Anonyme operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals.

Rewards

PE ratio (32.3x) is below the Healthcare industry average (32.3x)

Earnings are forecast to grow 12.01% per year

Pays a reliable dividend of 1.06%

Risk Analysis

Debt is not well covered by operating cash flow



Snowflake Analysis

Average dividend payer with moderate growth potential.


Similar Companies

Share Price & News

How has ORPEA Société Anonyme's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: ORP has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

1.2%

ORP

1.5%

FR Healthcare

-0.9%

FR Market


1 Year Return

22.4%

ORP

15.4%

FR Healthcare

20.4%

FR Market

Return vs Industry: ORP exceeded the French Healthcare industry which returned 15.4% over the past year.

Return vs Market: ORP exceeded the French Market which returned 20.4% over the past year.


Shareholder returns

ORPIndustryMarket
7 Day1.2%1.5%-0.9%
30 Day2.7%2.2%-0.3%
90 Day0.5%2.2%3.8%
1 Year23.8%22.4%18.1%15.4%24.4%20.4%
3 Year57.9%53.1%55.2%48.6%42.4%28.8%
5 Year137.6%124.7%87.2%74.2%74.6%49.6%

Price Volatility Vs. Market

How volatile is ORPEA Société Anonyme's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is ORPEA Société Anonyme undervalued compared to its fair value and its price relative to the market?

32.27x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: ORP (€113.6) is trading above our estimate of fair value (€33.67)

Significantly Below Fair Value: ORP is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: ORP is good value based on its PE Ratio (32.3x) compared to the Healthcare industry average (32.3x).

PE vs Market: ORP is poor value based on its PE Ratio (32.3x) compared to the French market (17.7x).


Price to Earnings Growth Ratio

PEG Ratio: ORP is poor value based on its PEG Ratio (2.7x)


Price to Book Ratio

PB vs Industry: ORP is good value based on its PB Ratio (2.5x) compared to the FR Healthcare industry average (2.5x).


Next Steps

Future Growth

How is ORPEA Société Anonyme forecast to perform in the next 1 to 3 years based on estimates from 11 analysts?

12.0%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: ORP's forecast earnings growth (12% per year) is above the savings rate (-0.1%).

Earnings vs Market: ORP's earnings (12% per year) are forecast to grow faster than the French market (11.6% per year).

High Growth Earnings: ORP's earnings are forecast to grow, but not significantly.

Revenue vs Market: ORP's revenue (6.1% per year) is forecast to grow faster than the French market (4.7% per year).

High Growth Revenue: ORP's revenue (6.1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: ORP's Return on Equity is forecast to be low in 3 years time (8.6%).


Next Steps

Past Performance

How has ORPEA Société Anonyme performed over the past 5 years?

13.8%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: ORP has high quality earnings.

Growing Profit Margin: ORP's current net profit margins (6.4%) are lower than last year (7.3%).


Past Earnings Growth Analysis

Earnings Trend: ORP's earnings have grown by 13.8% per year over the past 5 years.

Accelerating Growth: ORP's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: ORP had negative earnings growth (-4.9%) over the past year, making it difficult to compare to the Healthcare industry average (-13.4%).


Return on Equity

High ROE: ORP's Return on Equity (7.8%) is considered low.


Return on Assets


Return on Capital Employed


Next Steps

Financial Health

How is ORPEA Société Anonyme's financial position?


Financial Position Analysis

Short Term Liabilities: ORP's short term assets (€2.1B) do not cover its short term liabilities (€2.2B).

Long Term Liabilities: ORP's short term assets (€2.1B) do not cover its long term liabilities (€9.2B).


Debt to Equity History and Analysis

Debt Level: ORP's debt to equity ratio (221.6%) is considered high.

Reducing Debt: ORP's debt to equity ratio has increased from 182.1% to 221.6% over the past 5 years.

Debt Coverage: ORP's debt is not well covered by operating cash flow (7.3%).

Interest Coverage: ORP's interest payments on its debt are well covered by EBIT (3.2x coverage).


Balance Sheet

Inventory Level: ORP has a high level of physical assets or inventory.

Debt Coverage by Assets: ORP's debt is not covered by short term assets (assets are 0.3x debt).


Next Steps

Dividend

What is ORPEA Société Anonyme's current dividend yield, its reliability and sustainability?

1.06%

Current Dividend Yield


Dividend Yield vs Market

company1.1%marketbottom25%1.5%markettop25%4.6%industryaverage1.7%forecastin3Years1.3%

Current dividend yield vs market & industry

Notable Dividend: ORP's dividend (1.06%) isn’t notable compared to the bottom 25% of dividend payers in the French market (1.49%).

High Dividend: ORP's dividend (1.06%) is low compared to the top 25% of dividend payers in the French market (4.6%).


Stability and Growth of Payments

Stable Dividend: ORP's dividends per share have been stable in the past 10 years.

Growing Dividend: ORP's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (34.1%), ORP's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: ORP's dividends in 3 years are forecast to be well covered by earnings (35.3% payout ratio).


Next Steps

Management

What is the CEO of ORPEA Société Anonyme's salary, the management and board of directors tenure and is there insider trading?

4.0yrs

Average board tenure


CEO

Yves Le Masne (57yo)

8.8yrs

Tenure

€2,430,897

Compensation

Mr. Yves Le Masne has been the Chief Executive Officer of ORPEA Société Anonyme since February 15, 2011 and served as its Chief Financial Officer and Chief Operating Officer since 2006. Previously, Mr. Le  ...


CEO Compensation Analysis

Compensation vs Market: Yves's total compensation ($USD2.70M) is about average for companies of similar size in the French market ($USD2.64M).

Compensation vs Earnings: Yves's compensation has been consistent with company performance over the past year.


Board Age and Tenure

4.0yrs

Average Tenure

61.5yo

Average Age

Experienced Board: ORP's board of directors are considered experienced (4 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Management Team

  • Yves Le Masne (57yo)

    CEO & Director

    • Tenure: 8.8yrs
    • Compensation: €2.43m
  • Jean-Claude Brdenk (52yo)

    Chief Operating Officer

    • Tenure: 8.8yrs
    • Compensation: €2.02m
  • Steve Grobet

    Head of Investor Relations

    • Tenure: 0yrs
  • Yamina Emmungil

    Head of Legal Affairs

    • Tenure: 0yrs

Board Members

  • Xavier Coirbay (54yo)

    Independent Director

    • Tenure: 2.5yrs
    • Compensation: €41.56k
  • Yves Le Masne (57yo)

    CEO & Director

    • Tenure: 8.8yrs
    • Compensation: €2.43m
  • Philippe Charrier (65yo)

    Non-Executive Chairman

    • Tenure: 2.8yrs
    • Compensation: €297.56k
  • Thierry de Poncheville (64yo)

    Independent Director

    • Tenure: 7.8yrs
    • Compensation: €58.56k
  • Jean-Claude Marian (80yo)

    Honorary Chairman

    • Tenure: 2.8yrs
    • Compensation: €577.32k
  • Jean-Patrick Fortlacroix (62yo)

    Independent Director

    • Tenure: 8.5yrs
    • Compensation: €51.56k
  • Bernadette Chevallier-Danet (61yo)

    Independent Director

    • Tenure: 5.3yrs
    • Compensation: €42.06k
  • Sophie Kalaidjian (42yo)

    Director

    • Tenure: 4.9yrs
    • Compensation: €9.50k
  • Laure Baume (44yo)

    Independent Director

    • Tenure: 3yrs
    • Compensation: €39.56k
  • Brigitte Lantz (66yo)

    Independent Director

    • Tenure: 3yrs
    • Compensation: €37.56k

Company Information

ORPEA Société Anonyme's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: ORPEA Société Anonyme
  • Ticker: ORP
  • Exchange: ENXTPA
  • Founded: 1989
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: €7.212b
  • Shares outstanding: 64.57m
  • Website: https://www.orpea-corp.com

Number of Employees


Location

  • ORPEA Société Anonyme
  • 12 rue Jean Jaruès
  • CS 10032
  • Puteaux
  • Ile-de-France
  • 92813
  • France

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ORPENXTPA (Euronext Paris)YesOrdinary SharesFREURApr 2002
OPADB (Deutsche Boerse AG)YesOrdinary SharesDEEURApr 2002
0NEXLSE (London Stock Exchange)YesOrdinary SharesGBEURApr 2002
ORPE.FOTCPK (Pink Sheets LLC)YesOrdinary SharesUSUSDApr 2002
ORPPBATS-CHIXE (BATS 'Chi-X Europe')YesOrdinary SharesGBEURApr 2002

Biography

ORPEA Société Anonyme operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals. Its nursing care facilities provide personalized support servic ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/12/07 20:45
End of Day Share Price2019/12/06 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.